cephalostatin i has been researched along with helenalin in 1 studies
| Studies (cephalostatin i) | Trials (cephalostatin i) | Recent Studies (post-2010) (cephalostatin i) | Studies (helenalin) | Trials (helenalin) | Recent Studies (post-2010) (helenalin) |
|---|---|---|---|---|---|
| 10 | 0 | 3 | 149 | 1 | 43 |
| Protein | Taxonomy | cephalostatin i (IC50) | helenalin (IC50) |
|---|---|---|---|
| photoreceptor-specific nuclear receptor | Homo sapiens (human) | 1.921 | |
| XBP1 | Homo sapiens (human) | 2.43 | |
| type-1 angiotensin II receptor | Homo sapiens (human) | 18.639 | |
| G-protein coupled receptor 55 | Homo sapiens (human) | 2.6423 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 2.61 | |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | 4.374 | |
| Transcriptional activator Myb | Gallus gallus (chicken) | 2.3707 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pettit, GR | 1 |
1 review(s) available for cephalostatin i and helenalin
| Article | Year |
|---|---|
Progress in the discovery of biosynthetic anticancer drugs.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Drug Design; Humans; Structure-Activity Relationship | 1996 |